Drugs affecting lipid metabolism: risk factors and future directions
Saved in:
| Format: | Book |
|---|---|
| Language: | English |
| Published: |
Dordrecht [u.a.]
Kluwer
1996
|
| Series: | Medical science symposia series
10 |
| Subjects: | |
| Physical Description: | XIII, 700 S. Ill., graph. Darst. |
| ISBN: | 0792341678 |
Staff View
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV011073378 | ||
| 003 | DE-604 | ||
| 005 | 19961122 | ||
| 007 | t | ||
| 008 | 961121s1996 ad|| |||| 10||| eng d | ||
| 020 | |a 0792341678 |9 0-7923-4167-8 | ||
| 035 | |a (OCoLC)35086137 | ||
| 035 | |a (DE-599)BVBBV011073378 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-12 |a DE-355 | ||
| 050 | 0 | |a RC632.H87 | |
| 082 | 0 | |a 615/.739 |2 20 | |
| 084 | |a YC 7405 |0 (DE-625)153255:12911 |2 rvk | ||
| 245 | 1 | 0 | |a Drugs affecting lipid metabolism |b risk factors and future directions |c Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ... |
| 264 | 1 | |a Dordrecht [u.a.] |b Kluwer |c 1996 | |
| 300 | |a XIII, 700 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Medical science symposia series |v 10 | |
| 650 | 7 | |a Geneesmiddelen |2 gtt | |
| 650 | 7 | |a Lipiden |2 gtt | |
| 650 | 7 | |a Stofwisseling |2 gtt | |
| 650 | 4 | |a Antilipemic Agents |x therapeutic use |v Congresses | |
| 650 | 4 | |a Antilipemic agents |v Congresses | |
| 650 | 4 | |a Antioxidants |x Physiological effect |v Congresses | |
| 650 | 4 | |a Antioxidants |x therapeutic use |v Congresses | |
| 650 | 4 | |a Coronary heart disease |x Prevention |v Congresses | |
| 650 | 4 | |a Gene Therapy |v Congresses | |
| 650 | 4 | |a Hyperlipidemias |x drug therapy |v Congresses | |
| 650 | 4 | |a Lipid Metabolism |v Congresses | |
| 650 | 4 | |a Lipids |x Metabolism |v Congresses | |
| 650 | 4 | |a Risk Factors |v Congresses | |
| 650 | 0 | 7 | |a Lipidsenker |0 (DE-588)4167796-1 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hyperlipidämie |0 (DE-588)4161072-6 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 689 | 0 | 0 | |a Hyperlipidämie |0 (DE-588)4161072-6 |D s |
| 689 | 0 | 1 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Lipidsenker |0 (DE-588)4167796-1 |D s |
| 689 | 1 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Gotto, Antonio M. |e Sonstige |4 oth | |
| 830 | 0 | |a Medical science symposia series |v 10 |w (DE-604)BV008340509 |9 10 | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-007417590 | ||
Record in the Search Index
| _version_ | 1804125563828305920 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV011073378 |
| callnumber-first | R - Medicine |
| callnumber-label | RC632 |
| callnumber-raw | RC632.H87 |
| callnumber-search | RC632.H87 |
| callnumber-sort | RC 3632 H87 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | YC 7405 |
| ctrlnum | (OCoLC)35086137 (DE-599)BVBBV011073378 |
| dewey-full | 615/.739 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615/.739 |
| dewey-search | 615/.739 |
| dewey-sort | 3615 3739 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02255nam a2200601 cb4500</leader><controlfield tag="001">BV011073378</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19961122 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">961121s1996 ad|| |||| 10||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0792341678</subfield><subfield code="9">0-7923-4167-8</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)35086137</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV011073378</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield><subfield code="a">DE-355</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC632.H87</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.739</subfield><subfield code="2">20</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 7405</subfield><subfield code="0">(DE-625)153255:12911</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Drugs affecting lipid metabolism</subfield><subfield code="b">risk factors and future directions</subfield><subfield code="c">Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Dordrecht [u.a.]</subfield><subfield code="b">Kluwer</subfield><subfield code="c">1996</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIII, 700 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Medical science symposia series</subfield><subfield code="v">10</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Geneesmiddelen</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Lipiden</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Stofwisseling</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic Agents</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antilipemic agents</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antioxidants</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antioxidants</subfield><subfield code="x">therapeutic use</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Coronary heart disease</subfield><subfield code="x">Prevention</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Gene Therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Hyperlipidemias</subfield><subfield code="x">drug therapy</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipid Metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Lipids</subfield><subfield code="x">Metabolism</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Risk Factors</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hyperlipidämie</subfield><subfield code="0">(DE-588)4161072-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Lipidsenker</subfield><subfield code="0">(DE-588)4167796-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gotto, Antonio M.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Medical science symposia series</subfield><subfield code="v">10</subfield><subfield code="w">(DE-604)BV008340509</subfield><subfield code="9">10</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-007417590</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| id | DE-604.BV011073378 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:03:33Z |
| institution | BVB |
| isbn | 0792341678 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-007417590 |
| oclc_num | 35086137 |
| open_access_boolean | |
| owner | DE-12 DE-355 DE-BY-UBR |
| owner_facet | DE-12 DE-355 DE-BY-UBR |
| physical | XIII, 700 S. Ill., graph. Darst. |
| publishDate | 1996 |
| publishDateSearch | 1996 |
| publishDateSort | 1996 |
| publisher | Kluwer |
| record_format | marc |
| series | Medical science symposia series |
| series2 | Medical science symposia series |
| spelling | Drugs affecting lipid metabolism risk factors and future directions Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ... Dordrecht [u.a.] Kluwer 1996 XIII, 700 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Medical science symposia series 10 Geneesmiddelen gtt Lipiden gtt Stofwisseling gtt Antilipemic Agents therapeutic use Congresses Antilipemic agents Congresses Antioxidants Physiological effect Congresses Antioxidants therapeutic use Congresses Coronary heart disease Prevention Congresses Gene Therapy Congresses Hyperlipidemias drug therapy Congresses Lipid Metabolism Congresses Lipids Metabolism Congresses Risk Factors Congresses Lipidsenker (DE-588)4167796-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf Hyperlipidämie (DE-588)4161072-6 gnd rswk-swf (DE-588)1071861417 Konferenzschrift gnd-content Hyperlipidämie (DE-588)4161072-6 s Pharmakotherapie (DE-588)4076066-2 s DE-604 Lipidsenker (DE-588)4167796-1 s Pharmakologie (DE-588)4045687-0 s Gotto, Antonio M. Sonstige oth Medical science symposia series 10 (DE-604)BV008340509 10 |
| spellingShingle | Drugs affecting lipid metabolism risk factors and future directions Medical science symposia series Geneesmiddelen gtt Lipiden gtt Stofwisseling gtt Antilipemic Agents therapeutic use Congresses Antilipemic agents Congresses Antioxidants Physiological effect Congresses Antioxidants therapeutic use Congresses Coronary heart disease Prevention Congresses Gene Therapy Congresses Hyperlipidemias drug therapy Congresses Lipid Metabolism Congresses Lipids Metabolism Congresses Risk Factors Congresses Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakologie (DE-588)4045687-0 gnd Hyperlipidämie (DE-588)4161072-6 gnd |
| subject_GND | (DE-588)4167796-1 (DE-588)4076066-2 (DE-588)4045687-0 (DE-588)4161072-6 (DE-588)1071861417 |
| title | Drugs affecting lipid metabolism risk factors and future directions |
| title_auth | Drugs affecting lipid metabolism risk factors and future directions |
| title_exact_search | Drugs affecting lipid metabolism risk factors and future directions |
| title_full | Drugs affecting lipid metabolism risk factors and future directions Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ... |
| title_fullStr | Drugs affecting lipid metabolism risk factors and future directions Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ... |
| title_full_unstemmed | Drugs affecting lipid metabolism risk factors and future directions Fondazione Giovanni Lorenzini, Milan, Italy ... Ed. by A. M. Gotto ... |
| title_short | Drugs affecting lipid metabolism |
| title_sort | drugs affecting lipid metabolism risk factors and future directions |
| title_sub | risk factors and future directions |
| topic | Geneesmiddelen gtt Lipiden gtt Stofwisseling gtt Antilipemic Agents therapeutic use Congresses Antilipemic agents Congresses Antioxidants Physiological effect Congresses Antioxidants therapeutic use Congresses Coronary heart disease Prevention Congresses Gene Therapy Congresses Hyperlipidemias drug therapy Congresses Lipid Metabolism Congresses Lipids Metabolism Congresses Risk Factors Congresses Lipidsenker (DE-588)4167796-1 gnd Pharmakotherapie (DE-588)4076066-2 gnd Pharmakologie (DE-588)4045687-0 gnd Hyperlipidämie (DE-588)4161072-6 gnd |
| topic_facet | Geneesmiddelen Lipiden Stofwisseling Antilipemic Agents therapeutic use Congresses Antilipemic agents Congresses Antioxidants Physiological effect Congresses Antioxidants therapeutic use Congresses Coronary heart disease Prevention Congresses Gene Therapy Congresses Hyperlipidemias drug therapy Congresses Lipid Metabolism Congresses Lipids Metabolism Congresses Risk Factors Congresses Lipidsenker Pharmakotherapie Pharmakologie Hyperlipidämie Konferenzschrift |
| volume_link | (DE-604)BV008340509 |
| work_keys_str_mv | AT gottoantoniom drugsaffectinglipidmetabolismriskfactorsandfuturedirections |